Continuous Veno-Venous High Cut-Off Hemodialysis Compared to Continuous Veno-Venous Hemodiafiltration in Intensive Care Unit Acute Kidney Injury Patients.
Blood Purif
; 46(3): 248-256, 2018.
Article
em En
| MEDLINE
| ID: mdl-29972818
ABSTRACT
AIMS:
High cut-off (HCO) continuous veno-venous hemodialysis (CVVHD) was compared to high-flux membrane (HFM) continuous veno-venous hemodiafiltration (CVVHDF) in intensive care unit (ICU) acute kidney injury (AKI) in terms of efficiency, hemodynamic tolerance, medium-sized molecules removal, albumin loss, and inflammatory system activation.METHODS:
In a prospective cross-over randomized study, 10 AKI patients underwent successively HCO (Ultraflux EmiC2 ß2-microglobulin [ß2M] sieving coefficient [SC] 0.9) CVVHD and HFM (Ultraflux AV1000S ß2M SC 0.65) -CVVHDF.RESULTS:
Over the 20 sessions, hypotensive and febrile episodes, reduction rates of urea, creatinine, and ß2M were similar in both modalities. Though dialysis dose was higher with CVVHDF (36 ± 4 vs. 21 ± 6 mL/Kg/h), urea, creatinine, and ß2M instantaneous and plasmatic clearances did not differ except for urea at 12 h. Protein loss, superoxide anion production, cytokines, and growth factors variations were also comparable.CONCLUSION:
HCO CVVHD is well tolerated and is as effective as HFM CVVHDF in clearance of solutes and removal of ß2M. It induces neither protein loss nor overproduction of superoxide anion. Video Journal Club "Cappuccino with Claudio Ronco" at http//www.karger.com/?doi=489082.Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Hemodiafiltração
/
Cuidados Críticos
/
Injúria Renal Aguda
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Blood Purif
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
França